CLINICAL_TRIALS
trial_result
· 2024-10-23
Clinical Trial Update: A Phase 2, Open Label, Pharmacokinetic (PK) Study of TLC599 in Subjects With Osteoarthritis of the Knee [Phase 2]
Summary
Phase 2 open-label pharmacokinetic study of TLC599 in osteoarthritis of the knee completed; results pending release.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Taiwan Liposome Company | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED